Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets
Tuesday, 17th December at 9:00 am
Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.
Hyperfine, Inc. (NASDAQ: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced further global expansion of its commercial operations through agreements with experienced distributors to support commercial expansion plans of the Swoop® system into Turkey, Israel, and Saudi Arabia. These distribution agreements strengthen the company's global expansion strategy, broadening access to MR brain imaging in regions with large populations, low penetration of MRI, and significant unmet healthcare needs.